- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02331459
Training Intervention in a Controlled Population of Frail Elderly (EMTIFE)
Effect of a Multicomponent Training Intervention on Cognition, Mood, and Function in a Controlled Population of Community-dwelling Frail Elderly Patients.
Exercise has a beneficial role in geriatric patients categorized as frail. Nevertheless, it is not known physical training pattern more beneficial for these patients. The reasons for heterogeneity and lack of consistency of the results described by published intervention programs may be the diversity of isolated - resistance, endurance or proprioceptive trainings - or a combination of them. There are no studies with a combined program of this three kinds of physical training.
The objective of this study is to know if a multicomponent physical training program during 180 days in dwelling-community frail geriatric patients can improve scores on functional, activities of daily living, mood, cognitive and quality of life scales and producing changes in blood levels of biological and genetic markers.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
At the start of recruitment, a comprehensive geriatric assessment will be developed in enrolled patients of both groups. After this assessment and before starting the physical training in intervention group, a nutritional intervention will be provided in patients of both groups :
Enrolled patients will receive nutritional information on optimal daily energy intake, ensuring at least a daily protein intake of 1 g. of by kg of weight.
As well as, calcium and vitamin D will be provided if calcidiol blood levels are lower than 30 ng/ml.
Calcidiol blood value between 20-29 ng/dl it will provide calcium + vitamin D (total amount 1200 mg calcium plus 800 IU of vitamin D) daily and calciferol 20.000 IU every 15 days (3 months)
Calcidiol blood value between 10-19 ng/dl it will provide calcium + vitamin D (total amount 1200 mg calcium plus 800 IU of vitamin D) daily and calciferol 20.000 IU every 10 days (3 months)
Calcidiol blood value between 1-9 ng/dl it will provide calcium + vitamin D (total amount 1200 mg calcium plus 800 IU of vitamin D) daily and calciferol 20.000 IU every 7 days (3 months)
After nutritional intervention, intervention group will start a multicomponent training intervention during 180 days Intervention characteristics: 24weeks, 5days/week, 60min/session Day 1, 3 and 5 15 min (a) 40 min (b) 5 min (d) Day 2 and 4 15 min (a) 40 min (c) 5 min (d)
Legend:
min. =minutes a = Proprioception exercises, postural sway and dynamic balance, coordination and flexibility of the lumbo-pelvic area b = Aerobic training 65% HRmax c = Strength training arms and legs d = Stretching Characteristics of the strength training Month 1 Week 1 25% 1-RM 1x30 r Week 2 25% 1-RM 2x30 r Week 3-4 25% 1-RM 3x30 r Month 2 Week 1-4 25% 1-RM 3x30 r Month 3 Week 1 50% 1-RM 1x15 r Week 2 50% 1-RM 2x10 r Week 3-4 50% 1-RM 3x8 r Month 4 Week 1-4 50% 1-RM 3x8 r Month 5 Week 1 75% 1-RM 1x15 r Week 2 75% 1-RM 2x10 r Week 3-4 75% 1-RM 3x8 r Month 6 Week 1-4 75% 1-RM 3x8 r
Legend:
1-RM: One-repetition maximum r: repetitions
Monthly, enrolled frail elderly patients will be evaluated. 6 minutes walking test, timed up and go test, bilateral hand grip, Barthel index, Tinetti balance assessment tool, Mini-mental state examination, short-MNA (Mini Nutritional Assessment ), lean and fat mass measures with impedanciometer and number of visits to general practitioner, emergency room and hospital admission were recorded.
After follow up period a new comprehensive geriatric assessment will be recorded.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Valéncia
-
Alzira, Valéncia, Spain, 46600
- Hospital Universitario de La Ribera
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- - Dwelling-community subjects
- - Age 70 years old and older
- Frail geriatric patient according to the Cardiovascular Health Study (CHS) Frailty Phenotype
- Gait speed less than 0.8 m/s.
Exclusion Criteria:
- - Life expectancy less than 6 months for any clinical reason (we considered criteria of a life expectancy less than 6 months 7 c-7 d global deterioration degree on GDS (Global Deterioration Scale)-FAST (Functional Assessment Staging ) scale in patients with dementia; severe disabilities considered as score less than 15 points in Barthel index and left ventricular ejection fraction equal or less than 20%)
- - Hospital Admission in the last 3 months for any clinical reason
- - oncologic patients in chemotherapy or radiotherapy active treatment
- - Major surgery in the last 6 months
- - First-degree centenary relatives in the two previous generations
- - Ischemic coronary event in the last 12 months
- Institutionalized subjects
- Impossibility of displacement to the Health Center by themselves.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Multicomponent training intervention : 3 sessions a week of 45 minutes of resistance activity (24 weeks) 2 sessions a week of 45 minutes of strength training (24 weeks) 5 sessions a week of 15 minutes of proprioceptive training (24 weeks) |
Intervention characteristics: 24weeks, 5days/week, 60min/session Day 1, 3 and 5 15 min (a) 40 min (b) 5 min (d) Day 2 and 4 15 min (a) 40 min (c) 5 min (d) Legend: min. =minutes a = Proprioception exercises, postural sway and dynamic balance, coordination and flexibility of the lumbo-pelvic area b = Aerobic training 65% maximal Heart rate c = Strength training arms and legs d = Stretching Enrolled patients will receive nutritional information on optimal daily energy intake, ensuring at least a daily protein intake of 1 g. of by kg of weight. Calcium plus vitamin D (total amount 1200 mg calcium plus 800 IU of vitamin D) Vitamin D will be provided if calcidiol (Cldl) blood levels are lower than 30 ng/ml. Cldl 20-29 ng/dl it will provide calciferol 20.000 IU every 15 days (3 months) Cldl 10-19 ng/dl it will provide calciferol 20.000 IU every 10 days (3 months) Cldl 1-9 ng/dl it will provide calciferol 20.000 IU every 7 days (3 months) |
Placebo Comparator: Control group
Normal routine during 24 weeks.
|
Enrolled patients will receive nutritional information on optimal daily energy intake, ensuring at least a daily protein intake of 1 g. of by kg of weight. Calcium plus vitamin D (total amount 1200 mg calcium plus 800 IU of vitamin D) Vitamin D will be provided if calcidiol (Cldl) blood levels are lower than 30 ng/ml. Cldl 20-29 ng/dl it will provide calciferol 20.000 IU every 15 days (3 months) Cldl 10-19 ng/dl it will provide calciferol 20.000 IU every 10 days (3 months) Cldl 1-9 ng/dl it will provide calciferol 20.000 IU every 7 days (3 months) |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Activities of daily living.
Time Frame: Day 0 and Day 180 (plus or minus 3 days)
|
The primary study endpoint is the change from baseline to the end of the intervention, and the change between the intervention group and the control group, in score of Barthel Activities of Daily Living Index and the Lawton Instrumental Activities of Daily Living Scale
|
Day 0 and Day 180 (plus or minus 3 days)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mini-Mental State Examination (MMSE)
Time Frame: Day 0 and Day 180 (plus or minus 3 days)
|
Change from baseline to the end of the intervention, and the change between the intervention group and the control group.
|
Day 0 and Day 180 (plus or minus 3 days)
|
Short Physical Performance Battery and Physical Performance Test
Time Frame: Day 0 and Day 180 (plus or minus 3 days)
|
Change from baseline to the end of the intervention, and the change between the intervention group and the control group.
|
Day 0 and Day 180 (plus or minus 3 days)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Geriatric Depression Scale
Time Frame: Day 0 and Day 180 (plus or minus 3 days)
|
Change from baseline to the end of the intervention, and the change between the intervention group and the control group.
|
Day 0 and Day 180 (plus or minus 3 days)
|
Quality of life: EuroQol-5D
Time Frame: Day 0 and Day 180 (plus or minus 3 days)
|
Change from baseline to the end of the intervention, and the change between the intervention group and the control group.
|
Day 0 and Day 180 (plus or minus 3 days)
|
Composite effect of a multicomponent training intervention on systemic biomarkers of frailty
Time Frame: Day 0 and Day 180 (plus or minus 3 days)
|
|
Day 0 and Day 180 (plus or minus 3 days)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Pilar Pérez-Ros, PhD, Catholic University of Valencia San Vicente Mártir
- Study Chair: Francisco Martínez-Arnau, PhD, University of Valencia
- Study Director: Jose Vina, MD,PhD, Univeristy of Valencia
- Study Chair: Carmen Gómez-Cabrera, PhD, University of Valencia
- Principal Investigator: Francisco J Tarazona-Santabalbina, MD, PhD, Hospital de la Ribera
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- HULR-EMTIFE-2013-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Activity
-
Istinye UniversityCompletedPhysical Activity | Youth | Physical Activity Barriers | Physical Activity FacilitatorsTurkey
-
Istanbul Kültür UniversityWithdrawnPhysical Activity Level | Physical Activity Awareness
-
Georgetown UniversityUniversity of PennsylvaniaCompletedPhysical Activity | Motor ActivityUnited States
-
Assistance Publique - Hôpitaux de ParisTerminatedPhysical Activity | Physical DisabilityFrance
-
University of Colorado, DenverCompletedPhysical Activity | Physical ImpairmentUnited States
-
PXL University CollegeHasselt UniversityNot yet recruitingPhysical Activity - Digital Phenotyping - Activity Tracking
-
University of ExtremaduraThe Spanish Ministry of Science, Innovation and UniversitiesRecruitingPhysical Activity | Cognition | Physical Fitness | AdolescentsSpain
-
AdventHealth Translational Research InstituteWake Forest UniversityRecruiting
-
Wake Forest University Health SciencesMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases... and other collaboratorsRecruitingPhysical ActivityUnited States
-
Wake Forest University Health SciencesMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases... and other collaboratorsRecruiting
Clinical Trials on Multicomponent training intervention
-
Geisinger ClinicRecruiting
-
University of Sao PauloRecruitingInflammation | Obesity | Aging DisorderBrazil
-
Universitat Internacional de CatalunyaNot yet recruitingSarcopenia | Exercise Addiction | Old Age; DebilitySpain
-
Universidade Federal de Sao CarlosCompleted
-
Duke-NUS Graduate Medical SchoolCompleted
-
Servicio Canario de SaludInstituto de Salud Carlos IIICompletedSystemic Lupus ErythematosusSpain
-
Hospital Universitario GetafeKarolinska Institutet; Medical University of Lodz; Universidad Politecnica de... and other collaboratorsUnknownFrail Elderly Syndrome | Frailty | Frailty SyndromePoland, Spain, Sweden
-
University of BergamoCompleted
-
University Rovira i VirgiliDiputació de TarragonaCompletedDiet Modification | Food Preferences | Diet Habit | Food Allergy | Food Intolerance | InterventionSpain
-
University of PittsburghHealth Resources and Services Administration (HRSA)Completed